Source: Bloom Health Partners
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Bloom Health Partners (BLMH) has closed the second tranche of its non-brokered private placement
  • Under the second tranche, the company issued 2,770,000 units at $0.20 per unit for gross proceeds of $554,000
  • The company has sold a total of 7,920,000 units for aggregate gross proceeds of $1,584,000 
  • Net proceeds will be used for ongoing working capital and corporate development
  • Bloom Health Partners Inc. is a global platform for healthcare security, diagnostic testing and occupational health-tech
  • Bloom Health Partners Inc. (BLMH) opened trading at $0.195 per share

Bloom Health Partners (BLMH) has closed the second tranche of its previously announced non-brokered private placement.

Under the second tranche, the company issued 2,770,000 units at $0.20 per unit for gross proceeds of $554,000.

Bloom Health has sold a total of 7,920,000 units for gross proceeds of C$1,584,000. 

Units consist of one common share and one-half of a transferable common share purchase warrant. Each whole warrant entitles the holder to acquire one additional common share for $0.30 until July 18, 2023.

Bloom Health Partners Inc. plans to use the net proceeds of the offering for ongoing working capital and corporate development.

In connection with closing the second tranche of the offering, the company paid $32,640 and issued 163,200 warrants to an arms-length party who assisted in introducing subscribers to the offering.

All securities issued are subject to a statutory hold until November 19, 2022.

Bloom Health Partners Inc. is a global platform for healthcare security, diagnostic testing and occupational health-tech.

Bloom Health Partners Inc. (BLMH) opened trading at $0.195 per share.

More From The Market Herald

" Diagnos (TSXV:ADK) closes non-brokered private placement

Diagnos (ADK) has closed its non-brokered private placement for gross proceeds of $500,000.
NurExone Exosomes

" NurExone (TSXV:NRX) reports Q3 2022 financial results & provides corporate update

NurExone Biologic (NRX) reported its financial results for the quarter ended September 30, 2022.

" Wellteq (CSE:WTEQ) announces shareholder approval for plan of arrangement with AHI

Wellteq Digital Health (WTEQ) has announced that holders of its common shares have approved its plan of arrangement.

" Empower Clinics (CSE:EPW) names new General Manager of Medisure Labs

Empower Clinics (EPW) has appointed Eric Christian as the new General Manager of its medical diagnostics laboratory business, Medisure Labs.